Last month, an average of about 350 people died each week from COVID, according to data from the CDC. With available vaccines ...

Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...

Returning U.S. manufacturing employment to a level that remotely resembles its historical peak will be an uphill battle,” the ...

The stock's fall snapped a four-day winning streak.

CHICAGO -- Adding the PI3K-pathway inhibitor inavolisib (Itovebi) to palbociclib (Ibrance) and fulvestrant significantly ...

Merck offers a 4.2% dividend yield but faces uncertainty with KEYTRUDA's LOE. Click here to find out why MRK stock is a Hold.

Those two descriptions definitely apply to the healthcare sector. People need healthcare products and services regardless of ...

Today, Benzinga 's options scanner spotted 33 uncommon options trades for Merck & Co. This isn't normal. The overall ...

The State of Kansas announced an $895 million capital expansion project at the Merck Animal Health manufacturing facility in ...

ZoomRx polled 50 experienced oncologists and hemato-oncologists about 20 cancer drugmakers, asking the doctors to rank the ...

Merck KGaA said that cohort A met the primary endpoint in the Phase II lupus trial but cohort B failed to meet its primary ...